Jack Lieberman

5.1k total citations · 1 hit paper
129 papers, 4.0k citations indexed

About

Jack Lieberman is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Jack Lieberman has authored 129 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 41 papers in Cancer Research and 35 papers in Molecular Biology. Recurrent topics in Jack Lieberman's work include Protease and Inhibitor Mechanisms (41 papers), Peptidase Inhibition and Analysis (32 papers) and Cystic Fibrosis Research Advances (20 papers). Jack Lieberman is often cited by papers focused on Protease and Inhibitor Mechanisms (41 papers), Peptidase Inhibition and Analysis (32 papers) and Cystic Fibrosis Research Advances (20 papers). Jack Lieberman collaborates with scholars based in United States. Jack Lieberman's co-authors include A Sastre, Charles Mittman, Ernest Beutler, Laima Gaidulis, Benjamin Winter, N. B. Kurnick, Akira Yoshida, Christopher Grace, Benjamin Littenberg and James C. Dixon and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jack Lieberman

123 papers receiving 3.4k citations

Hit Papers

Elevation of serum angiotension-converting-enzyme (ACE) l... 1975 2026 1992 2009 1975 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis
    1975 729 citations Jack Lieberman The American Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Lieberman United States 32 1.3k 1.2k 844 824 758 129 4.0k
Yukihiko Adachi Japan 42 1.4k 1.0× 1.0k 0.9× 865 1.0× 330 0.4× 1.0k 1.3× 205 6.3k
Paolo Geñtilini Italy 51 1.4k 1.1× 580 0.5× 851 1.0× 239 0.3× 536 0.7× 170 9.6k
Harvey L. Sharp United States 36 832 0.6× 542 0.5× 901 1.1× 443 0.5× 501 0.7× 138 4.6k
J Bariéty France 45 1.6k 1.2× 833 0.7× 383 0.5× 192 0.2× 642 0.8× 221 7.0k
Anthony P. Fletcher United States 37 777 0.6× 1.5k 1.2× 401 0.5× 1.0k 1.3× 205 0.3× 87 4.7k
Mario Chojkier United States 41 2.3k 1.8× 324 0.3× 800 0.9× 701 0.9× 577 0.8× 77 6.8k
Patrizia Moser Austria 37 1.2k 0.9× 680 0.6× 939 1.1× 434 0.5× 417 0.6× 112 4.2k
N. F. Voelkel United States 35 1.3k 1.0× 3.1k 2.6× 252 0.3× 468 0.6× 1.3k 1.7× 87 5.5k
Elias Kouroumalis Greece 43 1.0k 0.8× 586 0.5× 1.0k 1.2× 271 0.3× 341 0.4× 200 6.1k
M. J. Phillips Canada 29 973 0.7× 494 0.4× 758 0.9× 178 0.2× 322 0.4× 79 7.0k

Countries citing papers authored by Jack Lieberman

Since Specialization
Citations

This map shows the geographic impact of Jack Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Lieberman more than expected).

Fields of papers citing papers by Jack Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Lieberman. The network helps show where Jack Lieberman may publish in the future.

Co-authorship network of co-authors of Jack Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Lieberman. A scholar is included among the top collaborators of Jack Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Lieberman. Jack Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lieberman, Jack. (2015). Measurement of Sputum Viscosity in a Cone-Plate Viscometer1. American Review of Respiratory Disease.
2.
Leung, Felix W., et al.. (2005). Colonoscopic features of simvastatin-induced colitis suggest ischemia as an etiologic mechanism. Gastrointestinal Endoscopy. 62(1). 175–178. 9 indexed citations
3.
Grace, Christopher, et al.. (2001). Usefulness of Blood Culture for Hospitalized Patients Who Are Receiving Antibiotic Therapy. Clinical Infectious Diseases. 32(11). 1651–1655. 82 indexed citations
4.
Lieberman, Jack. (2000). Augmentation Therapy Reduces Frequency of Lung Infections in Antitrypsin Deficiency. CHEST Journal. 118(5). 1480–1485. 135 indexed citations
5.
Lieberman, Jack, et al.. (1995). Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementia. Neurobiology of Aging. 16(5). 747–753. 51 indexed citations
6.
Lieberman, Jack & David S. Bell. (1993). Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: A comparison to serum angiotensin-converting enzyme in sarcoidosis. The American Journal of Medicine. 95(4). 407–412. 17 indexed citations
7.
Allen, Suni G., et al.. (1991). ALPHA‐1 ANTITRYPSIN DEFICIENCY IN A PATIENT WITH WIDESPREAD PRURIGO NODULARIS. Australasian Journal of Dermatology. 32(3). 151–157. 7 indexed citations
8.
Lieberman, Jack, et al.. (1991). Intermediate Alpha1-Antitrypsin Deficiency with Apical Lung Bullae and Spontaneous Pneumothorax. CHEST Journal. 99(6). 1545–1546. 4 indexed citations
9.
Lieberman, Jack, Gordon N. Gephardt, & Leonard H. Calabrese. (1990). Urticaria, nephritis, and pseudotumor cerebri. Cleveland Clinic Journal of Medicine. 57(2). 197–201. 3 indexed citations
10.
Lieberman, Jack, et al.. (1990). Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis. The American Journal of the Medical Sciences. 299(2). 103–106.
11.
Lieberman, Jack. (1990). Intermediate Antitrypsin Deficiency. American Review of Respiratory Disease. 141(4_pt_1). 1078–1078. 2 indexed citations
12.
Hartmann, Niklas, Lindsey C. Henson, Jack Lieberman, et al.. (1989). 3,5,3′-Triiodothyroacetic Acid Therapy for Thyroid Hormone Resistance*. The Journal of Clinical Endocrinology & Metabolism. 69(2). 461–466. 63 indexed citations
13.
Lieberman, Jack & K. H. Tachiki. (1989). Effect of Menses, Estrogens and Hemolysis on a Serum-Lectin-Like Factor in Cystic Fibrosis. CHEST Journal. 95(1). 111–116. 2 indexed citations
14.
Lieberman, Jack & A Sastre. (1986). An Angiotensin-Converting Enzyme (ACE) Inhibitor in Human Serum. CHEST Journal. 90(6). 869–875. 23 indexed citations
15.
Lieberman, Jack, et al.. (1980). Serum Angiotensin-Converting Enzyme: Elevations in Diabetes Mellitus. Annals of Internal Medicine. 93(6). 825–826. 144 indexed citations
16.
Lieberman, Jack. (1975). The mechanisms of antitrypsin deficiency an their role in the pathogenesis of pulmonary emphysema. Lung. 152(1-3). 7–14. 2 indexed citations
17.
Lieberman, Jack. (1974). Is There a Venoarterial Difference in α-Antitrypsin Levels?. BMJ. 3(5923). 93–94. 3 indexed citations
18.
Dixon, James C., et al.. (1972). Alpha1-antitrypsin (A1AT) accumulation in livers of emphysematous patients with A1AT deficiency. Human Pathology. 3(3). 361–370. 81 indexed citations
19.
Lieberman, Jack, et al.. (1970). More on Antitrypsin Activity in Lung Disease. Annals of Internal Medicine. 72(3). 437–439. 1 indexed citations
20.
Lieberman, Jack. (1970). α 1 -Antitrypsin Deficiency. Science. 167(3920). 1015–1016. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukihiko Adachi Breakdown of academic impact, for papers by Paolo Geñtilini Breakdown of academic impact, for papers by Harvey L. Sharp Breakdown of academic impact, for papers by J Bariéty Breakdown of academic impact, for papers by Anthony P. Fletcher Breakdown of academic impact, for papers by Mario Chojkier Breakdown of academic impact, for papers by Patrizia Moser Breakdown of academic impact, for papers by N. F. Voelkel Breakdown of academic impact, for papers by Elias Kouroumalis Breakdown of academic impact, for papers by M. J. Phillips
Rankless by CCL
2026